Stay updated on XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial
Sign up to get notified when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.

Latest updates to the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRecruitment status now shows 'No longer looking for participants', and new help sections How to Read a Study Record, Common Questions, and How to Join a Study were added. The Intervention / Treatment heading was reformatted to Intervention/Treatment, and the revision note updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check21 days agoChange DetectedFooter revision label updated from v3.5.4 to v3.5.5, indicating a deployment of a newer page template. No visible changes to the page content or user-facing features.SummaryDifference0.1%

- Check43 days agoChange Detected- Revision updated from v3.5.3 to v3.5.4, indicating a site deployment or maintenance update. This does not change the study content or visible page information.SummaryDifference0.1%

- Check65 days agoChange DetectedThe site revision indicator was updated from **Revision: v3.5.2** to **Revision: v3.5.3** on the study details page.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision changed from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check101 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.